The oligopeptide transporter (Pept-1) in human intestine: Biology and function

被引:270
作者
Adibi, SA [1 ]
机构
[1] UNIV PITTSBURGH, SCH MED, DEPT MED, CLIN NUTR RES UNIT, PITTSBURGH, PA USA
关键词
D O I
10.1016/S0016-5085(97)70112-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The oligopeptide transporter (Pept-1), which is located in the intestinal brush border membrane, provides a major mechanism for protein absorption in the human intestine. Expression cloning of the gene encoding Pept-1 has predicted a 78,810-kilodalton protein consisting of 708 amino acid residues and possessing 12 putative membrane-spanning domains. The characterization of its function by in vivo and in vitro studies has shown that (1) it transports dipeptides and tripeptides but not free amino acids or peptides with move than three amino acid residues, and (2) its driving force for uphill transport requires proton binding and presence of an inside-negative membrane potential. There has also been cloning of a membrane protein (HPT-1) which appears to be associated with the oligopeptide transporter. However, the nature of association has not yet been determined. A human intestinal cell line (Caco-2), which expresses Pept-1, has been used to investigate the effects of metabolic and pathological factors on dipeptide transport. These studies suggest that the insulin stimulates dipeptide transport by increasing membrane insertion of oligopeptide transporter from a preformed cytoplasmic pool, and cholera toxin decreases dipeptide transport by inhibiting the activity of Pept-1 through an increase in the intracellular concentration of adenosine 3',5'-cyclic monophosphate. Lastly, Pept-1 seems to play important roles in nutritional and pharmacological therapies; for example, it has allowed the use of oligopeptides as a source of nitrogen for enteral feeding and the use of oral route for delivery of peptidomimetic drugs such as beta-lactam antibiotics.
引用
收藏
页码:332 / 340
页数:9
相关论文
共 55 条
[1]  
ADIBI S, 1968, Clinical Research, V16, P446
[2]  
ADIBI SA, 1967, GASTROENTEROLOGY, V52, P837
[3]   Renal assimilation of oligopeptides: Physiological mechanisms and metabolic importance [J].
Adibi, SA .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 272 (05) :E723-E736
[4]   METABOLISM OF INTRAVENOUSLY ADMINISTERED DIPEPTIDES IN RATS - EFFECTS ON AMINO-ACID POOLS, GLUCOSE CONCENTRATION AND INSULIN AND GLUCAGON-SECRETION [J].
ADIBI, SA ;
KRZYSIK, BA ;
DRASH, AL .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1977, 52 (02) :193-204
[5]   PROTEIN DIGESTION IN HUMAN INTESTINE AS REFLECTED IN LUMINAL, MUCOSAL, AND PLASMA AMINO-ACID CONCENTRATIONS AFTER MEALS [J].
ADIBI, SA ;
MERCER, DW .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (07) :1586-1594
[6]   KINETICS OF AMINO ACID ABSORPTION AND ALTERATIION OF PLASMA COMPOSITION OF FREE AMINO ACIDS AFTER INTESTINAL PERFUSION OF AMINO ACID MIXTURES [J].
ADIBI, SA ;
GRAY, SJ ;
MENDEN, E .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1967, 20 (01) :24-+
[7]   EVIDENCE FOR 2 DIFFERENT MODES OF TRIPEPTIDE DISAPPEARANCE IN HUMAN INTESTINE - UPTAKE BY PEPTIDE CARRIER SYSTEMS AND HYDROLYSIS BY PEPTIDE HYDROLASES [J].
ADIBI, SA ;
MORSE, EL ;
MASILAMANI, SS ;
AMIN, PM .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (06) :1355-1363
[8]   NUMBER OF GLYCINE RESIDUES WHICH LIMITS INTACT ABSORPTION OF GLYCINE OLIGOPEPTIDES IN HUMAN JEJUNUM [J].
ADIBI, SA ;
MORSE, EL .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (05) :1008-1016
[9]   FUNCTIONAL CHARACTERIZATION OF DIPEPTIDE TRANSPORT-SYSTEM IN HUMAN JEJUNUM [J].
ADIBI, SA ;
SOLEIMANPOUR, MR .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (05) :1368-1374
[10]  
ADIBI SA, 1974, GASTROENTEROLOGY, V67, P586